310 related articles for article (PubMed ID: 23559626)
1. Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates.
Crosby JR; Marzec U; Revenko AS; Zhao C; Gao D; Matafonov A; Gailani D; MacLeod AR; Tucker EI; Gruber A; Hanson SR; Monia BP
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1670-8. PubMed ID: 23559626
[TBL] [Abstract][Full Text] [Related]
2. Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC; Meijers JC; Monia BP; Levi M
J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk.
Zhang H; Löwenberg EC; Crosby JR; MacLeod AR; Zhao C; Gao D; Black C; Revenko AS; Meijers JC; Stroes ES; Levi M; Monia BP
Blood; 2010 Nov; 116(22):4684-92. PubMed ID: 20807891
[TBL] [Abstract][Full Text] [Related]
4. Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys.
Younis HS; Crosby J; Huh JI; Lee HS; Rime S; Monia B; Henry SP
Blood; 2012 Mar; 119(10):2401-8. PubMed ID: 22246038
[TBL] [Abstract][Full Text] [Related]
5. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
[TBL] [Abstract][Full Text] [Related]
6. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.
Tucker EI; Marzec UM; White TC; Hurst S; Rugonyi S; McCarty OJ; Gailani D; Gruber A; Hanson SR
Blood; 2009 Jan; 113(4):936-44. PubMed ID: 18945968
[TBL] [Abstract][Full Text] [Related]
7. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
[TBL] [Abstract][Full Text] [Related]
8. Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Büller HR; Bethune C; Bhanot S; Gailani D; Monia BP; Raskob GE; Segers A; Verhamme P; Weitz JI;
N Engl J Med; 2015 Jan; 372(3):232-40. PubMed ID: 25482425
[TBL] [Abstract][Full Text] [Related]
9. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
10. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
11. Congenital factor XI deficiency: an update.
Duga S; Salomon O
Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
[TBL] [Abstract][Full Text] [Related]
12. Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial.
Lorentz CU; Verbout NG; Wallisch M; Hagen MW; Shatzel JJ; Olson SR; Puy C; Hinds MT; McCarty OJT; Gailani D; Gruber A; Tucker EI
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):799-809. PubMed ID: 30700130
[TBL] [Abstract][Full Text] [Related]
13. Factor XI and contact activation as targets for antithrombotic therapy.
Gailani D; Bane CE; Gruber A
J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012
[TBL] [Abstract][Full Text] [Related]
14. Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease.
Ades M; Simard C; Vanassche T; Verhamme P; Eikelboom J; Mavrakanas TA
Semin Nephrol; 2023 Nov; 43(6):151484. PubMed ID: 38272779
[TBL] [Abstract][Full Text] [Related]
15. Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.
Zilberman-Rudenko J; Itakura A; Wiesenekker CP; Vetter R; Maas C; Gailani D; Tucker EI; Gruber A; Gerdes C; McCarty OJ
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):510-7. PubMed ID: 26769048
[TBL] [Abstract][Full Text] [Related]
16. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
[TBL] [Abstract][Full Text] [Related]
17. Targeting factor XI to prevent thrombosis.
Morrissey JH
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1454-5. PubMed ID: 23766384
[No Abstract] [Full Text] [Related]
18. Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives.
Vlădăreanu AM; Roşca A
Rom J Intern Med; 2024 Jun; 62(2):91-100. PubMed ID: 38153875
[TBL] [Abstract][Full Text] [Related]
19. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
20. Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model.
van Montfoort ML; Knaup VL; Marquart JA; Bakhtiari K; Castellino FJ; Hack CE; Meijers JC
Thromb Haemost; 2013 Nov; 110(5):1065-73. PubMed ID: 23925504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
